A case report of new onset graves' disease induced by SARS-CoV-2 infection or vaccine?

Walid Hamouche; Yahya El Soufi; Saleh Alzaraq; Belonwu Valentine Okafor; Fan Zhang; Christos Paras

doi:10.1016/j.jecr.2021.100104

A case report of new onset graves' disease induced by SARS-CoV-2 infection or vaccine?

J Clin Transl Endocrinol Case Rep. 2022 Mar:23:100104. doi: 10.1016/j.jecr.2021.100104. Epub 2021 Dec 17.

Authors

Walid Hamouche¹, Yahya El Soufi², Saleh Alzaraq³, Belonwu Valentine Okafor⁴, Fan Zhang^{5

6}, Christos Paras⁵

Affiliations

¹ Internal Medicine Department, Brookdale University Hospital Medical Center, 1 Brookdale Plaza, Brooklyn, NY, USA.
² Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon.
³ Faculty of Medicine, Jordan University of Science and Technology, Amman, Jordan.
⁴ Nnmadi Azikiwe University Teaching Hospital, Nnewi, Nigeria.
⁵ Division of Endocrinology, Diabetes & Metabolism, Brookdale University Hospital Medical Center, 1 Brookdale Plaza, Brooklyn, NY, USA.
⁶ Division of Endocrinology, Diabetes & Metabolism, State University of New York, Downstate Medical Center, 450 Clarkson Avenue, Brooklyn, NY, USA.

Abstract

The virus responsible for the COVID-19 pandemic continues to pose unmatched challenges in the world. It can cause systemic inflammation, which can lead to multiorgan involvement and subsequent damage. The relationship that possibly exists between the COVID-19 infection, the newly developed vaccines, and thyroid disease are still under extensive investigation. We are reporting the first case of new-onset graves' disease in a young, healthy man after COVID-19 infection and receiving a COVID-19 vaccine dose.

Keywords: COVID-19; Graves' disease; Hyperthyroidism; Vaccine.

Publication types

Case Reports